BMS-5

Item no.	M6145-10mg
Manufacturer	AbMole
CASRN	1338247-35-0
Amount	10mg
Category	Oncology Neuroscience Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Breast Cancer
Type	Inhibitors
Specific against	other
Purity	1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	LIMKI 3
Available
Target Information	Others
Molecular Weight	431, 29
Solubility	DMSO ≥ 30 mg/mL
Bioactivity information	BMS-5 (LIMKi 3) is a Potent LIM kinase inhibitor (IC50 values are 7 and 8 nM for LIMK1 and LIMK2 respectively).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M6145-10mg-safety-datasheet.pdf